Applied Digital Stock Rises on AI Cloud Spinoff Plan and ChronoScale Launch 
Lockheed Martin Secures $92.8M AEGIS Sustainment Contract from U.S. Navy 
Hyundai Faces Deadline on Russia Plant Buyback Amid Ukraine War and Sanctions 
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics 
Samsung Electronics Secures Annual U.S. Licence for China Chip Equipment Imports in 2026 
California DMV Proposes New Safety Rules for Autonomous Vehicles After Waymo Incidents 
Meta Acquires AI Startup Manus to Expand Advanced AI Capabilities Across Platforms 
Winter Storm Disrupts Northeast Travel as Snow and Ice Blanket New York, New Jersey 
Warner Bros. Discovery Shares Slide Amid Report of Potential Paramount Skydance Lawsuit 
Winter Storm Devin Triggers Massive Flight Cancellations and Travel Disruptions Across the U.S. 
Leapmotor Targets 4 Million Annual EV Sales as Global Expansion Accelerates 
BP’s Castrol Stake Sale Raises Debt Relief Hopes but Sparks Cash Flow Concerns 
Brazilian Oil Workers’ Strike Continues as Key Petrobras Union Rejects Proposal 
China’s LandSpace Takes Aim at SpaceX With Reusable Rocket Ambitions 
Nvidia and Groq Strike Strategic AI Inference Licensing Deal 
TSMC Honors Japanese Chip Equipment Makers With 2025 Supplier Awards 
LAGUNA HILLS, Calif., Nov. 21, 2016 -- Sonendo®, Inc. the developer of a breakthrough technology for the endodontic marketplace, announced today that Bjarne Bergheim, President and Chief Executive Officer, will be presenting at the upcoming Piper Jaffray 28th Annual Healthcare Conference in New York, NY on Tuesday, November 29th, 2016. The presentation will begin at 3:50 p.m. Eastern Time.
About the event, Bjarne Bergheim stated, “We look forward to participating in this year’s conference and sharing how the Sound Science® behind the GentleWave® Procedure is helping dentists meet the expectations of patients who want to save their teeth but don’t want a standard root canal treatment.”
About Sonendo®
Sonendo, Inc. is a privately held, venture-backed company developing innovative and disruptive technologies to transform dentistry by Saving Teeth Through Sound Science®. The first commercially available product from Sonendo, the GentleWave® System, available in the US, shows significant improvements in clinical efficacy and treatment efficiency when compared to standard root canal techniques1-2. For more information please visit: www.sonendo.com.
1Sigurdsson A et al. (2016) J Endod. 42:1040-48. 2Molina B et al. (2015) J Endod. 41:1701-05.
Forward-Looking Statements
This announcement contains forward-looking statements based on management's beliefs, assumptions and expectations on information currently available to management. All statements that address events or developments that we expect or anticipate will occur in the future are forward-looking statements, including without limitation our expectations on the timing and progress of research and development activities. Management believes that these forward-looking statements are reasonable as and when made. However, you should not place undue reliance on forward-looking statements because they speak only as of the date when made. Sonendo does not assume any obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Actual results, developments or events could differ materially from those disclosed in the forward-looking statements.
Media Contact: Bob Guyatt Vice President of Marketing 949.766.3636
